ONT093
| CAS No. | 216227-54-2 | Cat. No. | BCP24637 |
| Name | ONT093 | ||
| Synonyms | ONT-093; ONT 093; OC-144-093; OC 144-093; OC144-093; OC-144093; OC 144093; OC144093; Benzenamine; | ||
| Formula | C32H38N4O | M. Wt | 494.67 |
| Description | ONT-093, also known as OC-144-093, is an orally bioavailable P-glycoprotein pump inhibitor, for the potential reversal of multidrug resistance in patients undergoing cancer chemotherapy. ONT-093 could inhibit P-gp and reverse multidrug resistance at nM concentrations with no effect on paclitaxel pharmacokinetics. OC144-093 is the least non-specifically toxic Pgp inhibitor described to date, with an average cytostatic IC50 of >60 microM in 15 cell types. OC144-093 may represent an ideal candidate for use in enhancement of AED blood-brain barrier penetration. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | P glycoprotein | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.